Amgen Inc. Capital Expenditures
Amgen Inc. (AMGN) reported Capital Expenditures of $1.23 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-05
- Amgen Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $513.00M, a 39.02% increase year-over-year.
- Amgen Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $712.00M, a 73.24% increase year-over-year.
- Amgen Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $642.00M, a 73.05% increase year-over-year.
- Amgen Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $436.00M, a 69.65% increase year-over-year.
- Amgen Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $1.86B, a 69.53% increase from fiscal 2024.
- Amgen Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $1.10B, a 1.44% decline from fiscal 2023.
- Amgen Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $1.11B, a 18.80% increase from fiscal 2022.
- Amgen Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $936.00M, a 6.36% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $513.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.23B 10-Q · filed 2026-08-05 | $1.87B derived: sum of 3 quarters · filed 2026-08-05 | $2.30B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $712.00M 10-Q · filed 2026-05-01 | $1.35B derived: sum of 2 quarters · filed 2026-05-01 | $1.79B derived: sum of 3 quarters · filed 2026-05-01 | $2.16B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $642.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $1.08B derived: sum of 2 quarters · filed 2026-02-13 | $1.45B derived: sum of 3 quarters · filed 2026-08-05 | $1.86B 10-K · filed 2026-02-13 |
| 2025-09-30 | $436.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $805.00M derived: sum of 2 quarters · filed 2026-08-05 | $1.22B 10-Q · filed 2025-11-05 | $1.59B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $369.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $780.00M 10-Q · filed 2026-08-05 | $1.15B derived: sum of 3 quarters · filed 2026-08-05 | $1.41B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $411.00M 10-Q · filed 2026-05-01 | $782.00M derived: sum of 2 quarters · filed 2026-05-01 | $1.04B derived: sum of 3 quarters · filed 2026-05-01 | $1.28B derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $371.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $628.00M derived: sum of 2 quarters · filed 2026-02-13 | $866.00M derived: sum of 3 quarters · filed 2026-02-13 | $1.10B 10-K · filed 2026-02-13 |
| 2024-09-30 | $257.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $495.00M derived: sum of 2 quarters · filed 2025-11-05 | $725.00M 10-Q · filed 2025-11-05 | $974.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $238.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $468.00M 10-Q · filed 2025-08-06 | $717.00M derived: sum of 3 quarters · filed 2026-02-13 | $965.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $230.00M 10-Q · filed 2025-05-02 | $479.00M derived: sum of 2 quarters · filed 2026-02-13 | $727.00M derived: sum of 3 quarters · filed 2026-02-13 | $998.00M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $249.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $497.00M derived: sum of 2 quarters · filed 2026-02-13 | $768.00M derived: sum of 3 quarters · filed 2026-02-13 | $1.11B 10-K · filed 2026-02-13 |
| 2023-09-30 | $248.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $519.00M derived: sum of 2 quarters · filed 2024-10-31 | $863.00M 10-Q · filed 2024-10-31 | $1.20B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $271.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $615.00M 10-Q · filed 2024-08-07 | $955.00M derived: sum of 3 quarters · filed 2025-02-14 | $1.11B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $344.00M 10-Q · filed 2024-05-03 | $684.00M derived: sum of 2 quarters · filed 2025-02-14 | $844.00M derived: sum of 3 quarters · filed 2025-02-14 | $1.09B derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $340.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $500.00M derived: sum of 2 quarters · filed 2025-02-14 | $746.00M derived: sum of 3 quarters · filed 2025-02-14 | $936.00M 10-K · filed 2025-02-14 |
| 2022-09-30 | $160.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $406.00M derived: sum of 2 quarters · filed 2023-10-31 | $596.00M 10-Q · filed 2023-10-31 | $883.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | $246.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $436.00M 10-Q · filed 2023-08-04 | $723.00M derived: sum of 3 quarters · filed 2024-02-14 | $965.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | $190.00M 10-Q · filed 2023-04-28 | $477.00M derived: sum of 2 quarters · filed 2024-02-14 | $719.00M derived: sum of 3 quarters · filed 2024-02-14 | $904.00M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $287.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $529.00M derived: sum of 2 quarters · filed 2024-02-14 | $714.00M derived: sum of 3 quarters · filed 2024-02-14 | $880.00M 10-K · filed 2024-02-14 |
| 2021-09-30 | $242.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $427.00M derived: sum of 2 quarters · filed 2022-11-04 | $593.00M 10-Q · filed 2022-11-04 | $766.00M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-06-30 | $185.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $351.00M 10-Q · filed 2022-08-05 | $524.00M derived: sum of 3 quarters · filed 2023-02-09 | $659.00M derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-03-31 | $166.00M 10-Q · filed 2022-04-28 | $339.00M derived: sum of 2 quarters · filed 2023-02-09 | $474.00M derived: sum of 3 quarters · filed 2023-02-09 | $632.00M derived: sum of 4 quarters · filed 2023-02-09 |
| 2020-12-31 | $173.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $308.00M derived: sum of 2 quarters · filed 2023-02-09 | $466.00M derived: sum of 3 quarters · filed 2023-02-09 | $608.00M 10-K · filed 2023-02-09 |
| 2020-09-30 | $135.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $293.00M derived: sum of 2 quarters · filed 2021-11-03 | $435.00M 10-Q · filed 2021-11-03 | $623.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $158.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $300.00M 10-Q · filed 2021-08-04 | $488.00M derived: sum of 3 quarters · filed 2022-02-16 | $658.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $142.00M 10-Q · filed 2021-04-28 | $330.00M derived: sum of 2 quarters · filed 2022-02-16 | $500.00M derived: sum of 3 quarters · filed 2022-02-16 | $644.00M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $188.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $358.00M derived: sum of 2 quarters · filed 2022-02-16 | $502.00M derived: sum of 3 quarters · filed 2022-02-16 | $618.00M 10-K · filed 2022-02-16 |
| 2019-09-30 | $170.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $314.00M derived: sum of 2 quarters · filed 2020-10-29 | $430.00M 10-Q · filed 2020-10-29 | $655.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $144.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $260.00M 10-Q · filed 2020-07-29 | $485.00M derived: sum of 3 quarters · filed 2021-02-09 | $656.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $116.00M 10-Q · filed 2020-05-01 | $341.00M derived: sum of 2 quarters · filed 2021-02-09 | $512.00M derived: sum of 3 quarters · filed 2021-02-09 | $699.00M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $225.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $396.00M derived: sum of 2 quarters · filed 2021-02-09 | $583.00M derived: sum of 3 quarters · filed 2021-02-09 | $738.00M 10-K · filed 2021-02-09 |
| 2018-09-30 | $171.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $358.00M derived: sum of 2 quarters · filed 2019-10-30 | $513.00M 10-Q · filed 2019-10-30 | $666.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-06-30 | $187.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $342.00M 10-Q · filed 2019-07-31 | $495.00M derived: sum of 3 quarters · filed 2020-02-12 | $653.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2018-03-31 | $155.00M 10-Q · filed 2019-05-01 | $308.00M derived: sum of 2 quarters · filed 2020-02-12 | $466.00M derived: sum of 3 quarters · filed 2020-02-12 | $651.00M derived: sum of 4 quarters · filed 2020-02-12 |
| 2017-12-31 | $153.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $311.00M derived: sum of 2 quarters · filed 2020-02-12 | $496.00M derived: sum of 3 quarters · filed 2020-02-12 | $664.00M 10-K · filed 2020-02-12 |
| 2017-09-30 | $158.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $343.00M derived: sum of 2 quarters · filed 2018-10-31 | $511.00M 10-Q · filed 2018-10-31 | $738.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-06-30 | $185.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $353.00M 10-Q · filed 2018-07-27 | $580.00M derived: sum of 3 quarters · filed 2019-02-13 | $747.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2017-03-31 | $168.00M 10-Q · filed 2018-04-25 | $395.00M derived: sum of 2 quarters · filed 2019-02-13 | $562.00M derived: sum of 3 quarters · filed 2019-02-13 | $750.00M derived: sum of 4 quarters · filed 2019-02-13 |
| 2016-12-31 | $227.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $394.00M derived: sum of 2 quarters · filed 2019-02-13 | $582.00M derived: sum of 3 quarters · filed 2019-02-13 | $738.00M 10-K · filed 2019-02-13 |
| 2016-09-30 | $167.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $355.00M derived: sum of 2 quarters · filed 2017-10-26 | $511.00M 10-Q · filed 2017-10-26 | $716.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-06-30 | $188.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $344.00M 10-Q · filed 2017-07-26 | $549.00M derived: sum of 3 quarters · filed 2018-02-13 | $687.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2016-03-31 | $156.00M 10-Q · filed 2017-04-27 | $361.00M derived: sum of 2 quarters · filed 2018-02-13 | $499.00M derived: sum of 3 quarters · filed 2018-02-13 | $632.00M derived: sum of 4 quarters · filed 2018-02-13 |
| 2015-12-31 | $205.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $343.00M derived: sum of 2 quarters · filed 2018-02-13 | $476.00M derived: sum of 3 quarters · filed 2018-02-13 | $594.00M 10-K · filed 2018-02-13 |
| 2015-09-30 | $138.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $271.00M derived: sum of 2 quarters · filed 2016-10-28 | $389.00M 10-Q · filed 2016-10-28 | $592.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-06-30 | $133.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $251.00M 10-Q · filed 2016-07-29 | $454.00M derived: sum of 3 quarters · filed 2017-02-14 | $624.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2015-03-31 | $118.00M 10-Q · filed 2016-05-02 | $321.00M derived: sum of 2 quarters · filed 2017-02-14 | $491.00M derived: sum of 3 quarters · filed 2017-02-14 | $664.00M derived: sum of 4 quarters · filed 2017-02-14 |
| 2014-12-31 | $203.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $373.00M derived: sum of 2 quarters · filed 2017-02-14 | $546.00M derived: sum of 3 quarters · filed 2017-02-14 | $718.00M 10-K · filed 2017-02-14 |
| 2014-09-30 | $170.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $343.00M derived: sum of 2 quarters · filed 2015-11-02 | $515.00M 10-Q · filed 2015-11-02 | $716.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-06-30 | $173.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $345.00M 10-Q · filed 2015-08-05 | $546.00M derived: sum of 3 quarters · filed 2016-10-31 | $721.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2014-03-31 | $172.00M 10-Q · filed 2015-04-27 | $373.00M derived: sum of 2 quarters · filed 2016-10-31 | $548.00M derived: sum of 3 quarters · filed 2016-10-31 | $707.00M derived: sum of 4 quarters · filed 2016-10-31 |
| 2013-12-31 | $201.00M derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | $376.00M derived: sum of 2 quarters · filed 2016-10-31 | $535.00M derived: sum of 3 quarters · filed 2016-10-31 | $693.00M 8-K · filed 2016-10-31 |
| 2013-09-30 | $175.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $334.00M derived: sum of 2 quarters · filed 2014-10-29 | $492.00M 10-Q · filed 2014-10-29 | $692.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-06-30 | $159.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $317.00M 10-Q · filed 2014-08-05 | $517.00M derived: sum of 3 quarters · filed 2015-02-19 | $690.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2013-03-31 | $158.00M 10-Q · filed 2014-04-30 | $358.00M derived: sum of 2 quarters · filed 2015-02-19 | $531.00M derived: sum of 3 quarters · filed 2015-02-19 | $703.00M derived: sum of 4 quarters · filed 2015-02-19 |
| 2012-12-31 | $200.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $373.00M derived: sum of 2 quarters · filed 2015-02-19 | $545.00M derived: sum of 3 quarters · filed 2015-02-19 | $689.00M 10-K · filed 2015-02-19 |
| 2012-09-30 | $173.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $345.00M derived: sum of 2 quarters · filed 2013-10-29 | $489.00M 10-Q · filed 2013-10-29 | $713.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | $172.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $316.00M 10-Q · filed 2013-08-06 | $540.00M derived: sum of 3 quarters · filed 2014-02-24 | $660.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | $144.00M 10-Q · filed 2013-05-03 | $368.00M derived: sum of 2 quarters · filed 2014-02-24 | $488.00M derived: sum of 3 quarters · filed 2014-02-24 | $611.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | $224.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $344.00M derived: sum of 2 quarters · filed 2014-02-24 | $467.00M derived: sum of 3 quarters · filed 2014-02-24 | $567.00M 10-K · filed 2014-02-24 |
| 2011-09-30 | $120.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $243.00M derived: sum of 2 quarters · filed 2012-11-06 | $343.00M 10-Q · filed 2012-11-06 | $525.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $123.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $223.00M 10-Q · filed 2012-08-08 | $405.00M derived: sum of 3 quarters · filed 2013-02-27 | $532.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $100.00M 10-Q · filed 2012-05-08 | $282.00M derived: sum of 2 quarters · filed 2013-02-27 | $409.00M derived: sum of 3 quarters · filed 2013-02-27 | $586.00M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $182.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $309.00M derived: sum of 2 quarters · filed 2013-02-27 | $486.00M derived: sum of 3 quarters · filed 2013-02-27 | $580.00M 10-K · filed 2013-02-27 |
| 2010-09-30 | $127.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $304.00M derived: sum of 2 quarters · filed 2011-11-04 | $398.00M 10-Q · filed 2011-11-04 | $542.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-06-30 | $177.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-08 | $271.00M 10-Q · filed 2011-08-08 | $415.00M derived: sum of 3 quarters · filed 2012-02-29 | $545.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2010-03-31 | $94.00M 10-Q · filed 2011-05-10 | $238.00M derived: sum of 2 quarters · filed 2012-02-29 | $368.00M derived: sum of 3 quarters · filed 2012-02-29 | $507.00M derived: sum of 4 quarters · filed 2012-02-29 |
| 2009-12-31 | $144.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-29 | $274.00M derived: sum of 2 quarters · filed 2012-02-29 | $413.00M derived: sum of 3 quarters · filed 2012-02-29 | $530.00M 10-K · filed 2012-02-29 |
| 2009-09-30 | $130.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $269.00M derived: sum of 2 quarters · filed 2010-11-08 | $386.00M 10-Q · filed 2010-11-08 | $564.00M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-06-30 | $139.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | $256.00M 10-Q · filed 2010-08-09 | $434.00M derived: sum of 3 quarters · filed 2011-02-25 | |
| 2009-03-31 | $117.00M 10-Q · filed 2010-05-07 | $295.00M derived: sum of 2 quarters · filed 2011-02-25 | ||
| 2008-12-31 | $178.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $672.00M 10-K · filed 2011-02-25 | ||
| 2008-09-30 | $494.00M 10-Q · filed 2009-11-06 | |||
| 2007-12-31 | $1.27B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |